Search

This study evaluates the potential of Chlorella vulgaris sp. extracts as eco-friendly corrosion inhibitors for API 5L 42 Steel in a 1M HCl acidic environment, offering sustainable alternatives for industrial applications. Two corrosion inhibitors were obtained through solvent extraction methods: M1 (methanol) and M2 (methanol/chloroform). The extracts were characterized using infrared spectroscopy, the analysis revealed hydroxyl, methyl and vinyl groups as the most representative. The effect of corrosion inhibition was study by electrochemical impedance spectroscopy (EIS) and potentiodynamic polarization. The results show significant reductions in corrosion current density and increases in charge transfer resistance, with M2 achieving the highest protection efficiency of 91.20 % and a charge transfer resistance of 501.80 Ω at a 120 ppm concentration, while M1 reached 88.22 % efficiency with a charge transfer resistance of 102.30 Ω. Uv–Vis measurements were performed to determine the electronic transitions of the metal-inhibitor system for each of the extracts. ANOVA highlighted the significant influence of biomass concentration on corrosion resistance. The adsorption of M1 and M2 extracts on the carbon steel surface obeyed the Langmuir isotherm and Gibbs free energy calculations indicated a physisorption mechanism for both extracts. Surface morphology analysis by Scanning electron microscope (SEM) revealed less pitting and reduced surface roughness as inhibitor concentration increased. These findings underscore the potential of Chlorella vulgaris extracts, particularly M2 at 120 ppm, as effective and sustainable corrosion inhibitors for steel in acidic environments.

Summary: Magnesium shows promise as a material for temporary fixation, yet its rapid corrosion poses health risks due to metal ion release. To mitigate these concerns, a biofunctionalization approach involving dicalcium phosphate dihydrate (DCPD) compounds and Chlorella sp. biomass was employed via electrodeposition, silanization, and dip-coating. Surface characterization using XRD, FTIR, and SEM confirmed successful deposition and immobilization. Corrosion behavior was assessed through electrochemical, immersion, and atomic absorption tests, revealing improved resistance and reduced Mg2+ ion release. The coatings demonstrated significant enhancement in corrosion resistance, guarding against pitting and cracks. The findings suggest the potential of Mg/DCPD and Mg/DCPD/microalgae coatings in addressing corrosion-related risks in temporary fixation applications, promising improved biocompatibility and longevity for medical implants.

Magnesium alloys have been extensively studied as degradable biomaterials for clinical applications due to their biocompatibility and mechanical properties. However, their poor corrosion resistance can lead to issues such as osteolysis and the release of gaseous hydrogen. This study investigated the influence of the activation time of magnesium surfaces in a sodium hydroxide (NaOH) solution on the concentration of active hydroxyl groups and corrosion resistance. The results indicated that immersion time significantly influences the formation of a corrosion-resistant film and the distribution of surface hydroxyl groups. Specifically, specimens treated for 7.5 h exhibited the highest concentration of hydroxyl groups and the most uniform oxide film distribution. Electrochemical tests demonstrated capacitive behavior and passive surface formation for all evaluated times, with the 7.5-h immersion in NaOH yielding superior corrosion resistance, lower current density, and a more efficient and thicker protective film. SEM and EDS analyses confirmed increased formation of Mg(OH)₂ for samples treated for 5 and 7.5 h, while a 10-h treatment resulted in a brittle, porous layer prone to degradation. Statistical analysis using ANOVA and Fisher's LSD test corroborated these findings. The optimal 7.5-h alkali treatment enhanced magnesium's corrosion resistance and surface properties, making it a promising candidate for orthopedic implants. However, further studies are necessary to assess biocompatibility and physiological responses before clinical implementation.